Ann: Supplementary NYR-BI03 Study Confirm Strong Cardioprotection, page-2

  1. 1,430 Posts.
    lightbulb Created with Sketch. 190
    No FDA approved drug and closest drug being developed is Aptoll which has a 40 percent infarct protection compared to 86 percent with NYR as shown below. A 4 billion dollar market they will dominate and own now just first human dosing 1 month away



    https://hotcopper.com.au/data/attachments/6553/6553286-ad65e6c931ca3c4f39b87e13c617489c.jpg
    https://hotcopper.com.au/data/attachments/6553/6553289-b492a364bd704a64a14e453ac45db103.jpg

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
33.0¢
Change
-0.010(2.94%)
Mkt cap ! $69.60M
Open High Low Value Volume
34.0¢ 34.3¢ 32.5¢ $195.9K 589.3K

Buyers (Bids)

No. Vol. Price($)
2 14970 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 20100 1
View Market Depth
Last trade - 15.29pm 25/07/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.